Skip to content

nPhase

Clinical trial data platform for pharma sponsors

Raised to date

$15M

of $30M offered across 1 Form D filing

Still open
$15M
Investors
2
Last filed
Nov 17, 2026

About

nPhase builds a clinical data platform for pharmaceutical sponsors and research organizations. It combines a unified data management system (UDMS) for capturing and cleaning trial data with a statistical computing environment (SCE) that turns raw study data into submission-ready datasets. The company was founded in 2016 and also runs REDCap Cloud, an electronic data capture product for smaller studies.

One platform covers data capture through regulatory-ready datasets, and a top-5 pharma sponsor is migrating over 90 live pivotal trials onto it.

Funding

  • EquityFiled Nov 17, 2026Form D
    $15M/ $30M

Product

nPhase.ai

Clinical data management software

A clinical data platform made of UDMS, which captures, integrates, cleans and reports on trial data from sources such as EDC, eCOA, labs and wearables, and SCE, which automates SDTM mapping, ADaM and TLF generation and Pinnacle 21 validation.

  • Electronic data capture and integration of 70+ data sources
  • Automated edit checks and query management
  • Automated SDTM mapping, ADaM and TLF generation

Built for

Pharmaceutical sponsors and clinical research organizations

People on file